Combined Autophagy and Proteasome Inhibition for Multiple Myeloma: Preliminary Results of a Phase 1/2 Trial of Hydroxychloroquine and Standard Dose Bortezomib for Relapsed or Refractory Myeloma
暂无分享,去创建一个
J. Bradner | M. Carroll | R. Amaravadi | E. Stadtmauer | D. Vogl | L. Davis | P. Mangan | Brenda Shelly | C. Swider | Charles W. Nichols | D. Shank | C. Thompson | Mary Carberry